Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years
Hiroo Yokozeki(Tokyo Medical and Dental University), Haruko Nishie, Manabu Fujimoto(Osaka Gakuin University), Takayo Matsumura(Maruho (Japan)), Takeshi Fukumoto(Kyoto Prefectural University of Medicine), Nobuo Kanazawa, Keiko Manabe, Akihiko Asahina, Kazumoto Katagiri, Yoko Kataoka(Shiga University of Medical Science), Tetsuya Honda(Hamamatsu University School of Medicine), Hiroshi Komazaki(Maruho (Japan)), Masatoshi Abe, Ken Igawa(Dokkyo Medical University), Toshio Katsunuma, Norito Katoh(Kyoto Prefectural University of Medicine), Tomoyasu Hattori, Atsuyuki Igarashi(NTT Medical Center), Noriko Arase(The University of Osaka), Atsushi Fukunaga(Kobe University), Yoshiko Mizukawa, Tomomitsu Miyagaki(Peter MacCallum Cancer Centre), Takashi Matsuyama, Toshihisa Hamada(International University of Health and Welfare), Takeshi Nakahara(Kyushu University), Ken Hayashi(SHOWA Medical University), Shinichi Moriwaki, Yuki Mizutani, Satomi Igawa, Riichiro Abe(University Hospitals of the Ruhr-University of Bochum), Tohru Nagano(Kobe City Medical Center General Hospital), Shin‐ichi Ansai, Yuko Chinuki, Shinichi Imafuku, Nobuhiro Fujita, Akimichi Morita(Nagoya City University), Hiroshi Mitsui, Yasuhiro Kawachi, Jun Muto(Ehime University), Hiroyuki Murota(Nagasaki University), Tetsuya Higuchi, Hiroo Amano, Hideki Kamiya(Aichi Medical University), Atsuko Kato, Kentaro Matsumoto(Tohoku University), Takeo Idezuki, Ryuji Maruyama(Nitobe Memorial Nakano General Hospital), Akihiro Kume, Masao Fukuzawa
Cited by 18
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
|The Journal of Immunology|2001|957
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683